Clinical Trials Logo

Clinical Trial Summary

This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion. Half of participants will receive oral dydrogesterone, while the other half will receive oral placebo.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04788108
Study type Interventional
Source Chulalongkorn University
Contact
Status Completed
Phase Phase 4
Start date August 1, 2021
Completion date August 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT02420769 - Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion N/A
Withdrawn NCT01501890 - Progesterone for First Trimester Vaginal Bleeding N/A
Completed NCT02686112 - Pregnancy Outcome in Woman With Threatened Abortion N/A
Completed NCT03930212 - Progesterone Supplementation in Threatened Abortion Phase 4